Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Per Med ; 17(1): 55-65, 2020 01.
Artigo em Inglês | MEDLINE | ID: mdl-31597544

RESUMO

Aim: To determine UK genetic counselors' (UKGCs) opinion regarding 'the psychosocial component of the UKGC remit in the new genomics era'. Methods: Facilitated discussions at a national conference (2016) using interactive methodologies (58 participants). Results: UKGCs recognized the rapid rate of change emerging with advances in genomic science. Change will be required to the UKGC remit and the roles, rules, relationships and responsibilities that underpin it (29 topics identified). UKGCs supported their 'unique selling point'; integrating knowledge and the explicit focus on psychosocial aspects of genomic healthcare. By 2019, some of the aspirations have been achieved. Conclusion: UKGCs should proactively position themselves to capitalize on the challenges and opportunities of genomic healthcare to maximize patient benefit.


Assuntos
Aconselhamento Genético/psicologia , Genômica/métodos , Congressos como Assunto , Humanos , Relações Profissional-Paciente , Reino Unido
3.
Eur J Hum Genet ; 23(8): 996-1003, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-25758997

RESUMO

Ensuring patient access to genomic information in the face of increasing demand requires clinicians to develop innovative ways of working. This paper presents the first empirical prospective observational cohort study of UK multi-disciplinary genetic service delivery. It describes and explores collaborative working practices including the utilisation and role of clinical geneticists and non-medical genetic counsellors. Six hundred and fifty new patients referred to a regional genetics service were tracked through 850 clinical contacts until discharge. Referral decisions regarding allocation of lead health professional assigned to the case were monitored, including the use of initial clinical contact guidelines. Significant differences were found in the cases led by genetic counsellors and those led by clinical geneticists. Around a sixth, 16.8% (109/650) of referrals were dealt with by a letter back to the referrer or re-directed to another service provider and 14.8% (80/541) of the remaining patients chose not to schedule an appointment. Of the remaining 461 patients, genetic counsellors were allocated as lead health professional for 46.2% (213/461). A further 61 patients did not attend. Of those who did, 86.3% (345/400) were discharged after one or two appointments. Genetic counsellors contributed to 95% (784/825) of total patient contacts. They provided 93.7% (395/432) of initial contacts and 26.8% (106/395) of patients were discharged at that point. The information from this study informed a planned service re-design. More research is needed to assess the effectiveness and efficiency of different models of collaborative multi-disciplinary working within genetics services.


Assuntos
Aconselhamento Genético , Doenças Genéticas Inatas/epidemiologia , Genética Médica , Estudos de Coortes , Doenças Genéticas Inatas/diagnóstico , Doenças Genéticas Inatas/patologia , Humanos , Inquéritos e Questionários , Reino Unido
4.
Nurs Stand ; 28(14): 37-43, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24299385

RESUMO

This is the seventh article in a series examining how nurses can develop confidence and competence in genetics and genomics health care. This article focuses on identifying the nurse's awareness of genetic and genomic issues and the effect this has on his or her practice. It considers the importance of reflection in recognising these issues as well as areas where professional development in genetics and genomics may be beneficial.


Assuntos
Competência Clínica , Aconselhamento Genético , Autoavaliação (Psicologia) , Educação Continuada em Enfermagem , Humanos , Papel do Profissional de Enfermagem , Reino Unido
5.
Lasers Med Sci ; 20(1): 6-10, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-15909229

RESUMO

To determine the efficacy of Omnilux Revive facial treatment in skin rejuvenation, twenty-three volunteers received randomised 20 min treatments three times a week for three weeks to one half of their face, with the untreated side acting as control. Regular assessments were carried out, focusing on parameters of subject satisfaction, photographic assessments, skin elasticity (Cutometer) and skin hydration (Corneometer CM825). Ninety-one percent of the volunteers reported visible changes to their skin. Blinded photographic evaluation reported a clinical response in 59% of the subjects. Objective analysis failed to show statistically significant changes in skin hydration or elasticity. The Omnilux Revive LED lamp is a safe alternative non-ablative skin rejuvenation treatment.


Assuntos
Fármacos Dermatológicos/uso terapêutico , Fototerapia/métodos , Envelhecimento da Pele/efeitos dos fármacos , Adulto , Dermabrasão/métodos , Elasticidade , Estética , Face , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Satisfação do Paciente , Valores de Referência , Rejuvenescimento , Medição de Risco , Método Simples-Cego , Resultado do Tratamento
6.
Adv Skin Wound Care ; 16(6): 317-27, 2003 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-14652518

RESUMO

OBJECTIVE: To determine whether a viscoelastic polymer (energy absorbing) foam mattress was superior to a standard hospital mattress for pressure ulcer prevention and to analyze the cost-effectiveness in comparison with standard hospital mattresses. DESIGN: Unblinded, randomized, prospective trial. SETTING: Elderly acute care, rehabilitation, and orthopedic wards at 3 hospitals in the United Kingdom. PARTICIPANTS: 1168 patients at risk of developing pressure ulcers (Waterlow score, 15 to 20), with a median age of 83 years (25th to 75th percentile range, 79-87). INTERVENTIONS: Participants were allocated to either the experimental equipment (CONFOR-Med mattress/cushion combination) or a standard mattress/cushion combination; all were given standard nursing care. Pressure areas were observed daily. MAIN OUTCOME MEASURE: Development of nonblanching erythema. RESULTS: A significant decrease in the incidence of blanching erythema (26.3% to 19.9%; P =.004) and a nonsignificant decrease in the incidence of nonblanching erythema occurred in participants allocated to the experimental equipment. However, when the survival curve plots were analyzed at 7 days, both categories showed statistically significant decreases (P =.0015 and P =.042, respectively). Participants on standard equipment had a relative odds ratio of 1.36 (95% confidence interval [CI], 1.10-1.69) for developing blanching erythema or worse and 1.46 (95% CI, 0.90-1.82) for developing nonblanching erythema or worse. To prevent nonblanching erythema, the number needed to treat (NNT) was 41.9 (95% CI, -82.6-15.3). To prevent any erythema (blanching or nonblanching), the NNT was 11.5 (95% CI, 41.6-9.3). Participants with blanching or nonblanching erythema were significantly less mobile than participants with normal skin and more likely to have worsening mobility (P <.001). For participants with similar pressure ulcer status, mattress type was not associated with difference in mobility. CONCLUSIONS: Regardless of prevention routine, pressure ulcers occur. In this study, the experimental equipment showed statistical significance to standard equipment for prevention of blanching erythema; significance was not achieved for nonblanching erythema. Trend and survival analysis show that a larger study is required to determine whether this nonsignificant difference is genuine.


Assuntos
Leitos/normas , Úlcera por Pressão/prevenção & controle , Idoso , Idoso de 80 Anos ou mais , Leitos/economia , Análise Custo-Benefício , Desenho de Equipamento/normas , Eritema/epidemiologia , Eritema/etiologia , Eritema/prevenção & controle , Feminino , Humanos , Masculino , Programas de Rastreamento , Avaliação em Enfermagem , Poliuretanos/normas , Úlcera por Pressão/economia , Úlcera por Pressão/epidemiologia , Úlcera por Pressão/etiologia , Estudos Prospectivos , Fatores de Risco , Análise de Sobrevida , Fatores de Tempo , Resultado do Tratamento , Reino Unido/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA